Shu Zhou - Shandong Weigao Non-Executive Director
| SHWGF Stock | USD 0.96 0.00 0.00% |
Director
Ms. Zhou Shu Hua is NonExecutive Director of Shandong Weigao Group Medical Polymer Company Limited. She is a nonexecutive Director of the Company and financial deputy general manager of Weigao Holding. Mrs. Zhou studied Business Administration at the Weihai Campus of Shandong University from 1999 to 2001. Mrs. Zhou joined Weigao Holding in 1989 and held a number of positions such as head of the finance division in the finance department, manager of the finance department and deputy general manager of Weigao Holding.
| Age | 60 |
| Phone | 86 63 1562 1999 |
| Web | https://www.weigaogroup.com |
Shandong Weigao Management Efficiency
The company has return on total asset (ROA) of 0.0604 % which means that it generated a profit of $0.0604 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1276 %, meaning that it generated $0.1276 on every $100 dollars invested by stockholders. Shandong Weigao's management efficiency ratios could be used to measure how well Shandong Weigao manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Mark Rubash | Intuitive Surgical | 61 | |
| Frank DiPasquale | Innovative Eyewear | 52 | |
| Martin Madden | Microbot Medical | 57 | |
| Michael Friedman | Intuitive Surgical | 73 | |
| Paul Richins | Utah Medical Products | 56 | |
| George Bell | Innovative Eyewear | 57 | |
| Yoav Waizer | Microbot Medical | 51 | |
| Barbara Payne | Utah Medical Products | 70 | |
| Yoseph Bornstein | Microbot Medical | 65 | |
| Scott Burell | Microbot Medical | 52 | |
| Solomon Mayer | Microbot Medical | 62 | |
| Moshe Shoham | Microbot Medical | 64 | |
| Craig Barratt | Intuitive Surgical | 55 | |
| Ernst Hoyer | Utah Medical Products | 79 | |
| Prattipati Laxminarain | Microbot Medical | 59 | |
| Eric Halvorson | Intuitive Surgical | 64 | |
| Amal Johnson | Intuitive Surgical | 65 | |
| James Beeson | Utah Medical Products | 75 | |
| Amy Ladd | Intuitive Surgical | N/A | |
| Don Kania | Intuitive Surgical | 63 | |
| Ralph Singer | Innovative Eyewear | 59 | |
Management Performance
| Return On Equity | 0.13 | |||
| Return On Asset | 0.0604 |
Shandong Weigao Group Leadership Team
Elected by the shareholders, the Shandong Weigao's board of directors comprises two types of representatives: Shandong Weigao inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Shandong. The board's role is to monitor Shandong Weigao's management team and ensure that shareholders' interests are well served. Shandong Weigao's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Shandong Weigao's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Junqiang Lu, Ex Director | ||
| Jia Li, Independent Non-Executive Director | ||
| Miu Wong, Company Secretary | ||
| Hong Ju, Vice-General Manager of the Production and Supply Chain | ||
| Hua Zhang, Vice Chairman, General Manager, Compliance Officer and Chairman of Corporate Governance Committee | ||
| Shu Zhou, Non-Executive Director | ||
| Jian Gong, Executive Director | ||
| Rinan Cong, CEO Director | ||
| Yi Wang, Deputy General Manager of General Affairs and Executive Director | ||
| Ming Fu, Independent Non-Executive Director | ||
| Jin Cui, CFO | ||
| Jinxia Wang, Independent Non-Executive Director | ||
| Jin Wang, Independent Non-Executive Director | ||
| Shili Ni, Ex Director | ||
| Xiu Song, Head - Sales Department | ||
| Wai Lo, Independent Non-Executive Director | ||
| Yuk Chan, Head - Business Development & Investor Relations | ||
| Xue Chen, Non-Executive Chairman of the Board | ||
| Lie Xia, Executive Director | ||
| De Zhou, Deputy General Manager - Blood Transfusion Division | ||
| Xue Wu, Chief Officer | ||
| Jing Long, Vice-General Manager of Marketing Management |
Shandong Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Shandong Weigao a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.13 | |||
| Return On Asset | 0.0604 | |||
| Profit Margin | 0.18 % | |||
| Operating Margin | 0.22 % | |||
| Current Valuation | 6.24 B | |||
| Shares Outstanding | 4.52 B | |||
| Shares Owned By Insiders | 46.39 % | |||
| Shares Owned By Institutions | 24.74 % | |||
| Price To Earning | 20.29 X | |||
| Price To Book | 2.20 X |
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Shandong Weigao Group. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the Shandong Weigao Group information on this page should be used as a complementary analysis to other Shandong Weigao's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Complementary Tools for Shandong Pink Sheet analysis
When running Shandong Weigao's price analysis, check to measure Shandong Weigao's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Shandong Weigao is operating at the current time. Most of Shandong Weigao's value examination focuses on studying past and present price action to predict the probability of Shandong Weigao's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Shandong Weigao's price. Additionally, you may evaluate how the addition of Shandong Weigao to your portfolios can decrease your overall portfolio volatility.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |